Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study
Silvia Stacchiotti, Giacomo Giulio Baldi, Anna Maria Frezza, Carlo Morosi, Francesca Gabriella Greco, Paola Collini, Marta Barisella, Gian Paolo Dagrada, Nadia Zaffaroni, Sandro Pasquali, Alessandro Gronchi, Paul H. Huang, Matilde Ingrosso, Gabriele Tinè, Rosalba Miceli, Paolo G. Casali
Topics & Concepts
RegorafenibMedicineDiscontinuationInternal medicineRefractory (planetary science)Progressive diseaseClinical endpointProgression-free survivalPhases of clinical researchGastroenterologyOncologyOverall survivalSurrogate endpointToxicityUrologySurgeryChemotherapyClinical trialCancerColorectal cancerAstrobiologyPhysicsSoft tissue tumor case studiesSarcoma Diagnosis and TreatmentIgG4-Related and Inflammatory Diseases